Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
13.45
+0.05 (0.37%)
At close: May 26, 2026, 4:00 PM EDT
13.50
+0.05 (0.37%)
After-hours: May 26, 2026, 7:08 PM EDT
Surgery Partners Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Surgery Partners stock has a consensus rating of "Buy" and an average price target of $17.95. The average 1-year stock price forecast is 33.46% higher than the current stock price, while the lowest is $14 (+4.09%) and the highest is $24 (+78.44%).
Price Target: $17.95 (+33.46%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Surgery Partners stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $18 | Buy | Maintains | $18 | +30.11% | May 14, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $20 | Buy | Maintains | $20 | +48.70% | May 13, 2026 |
| Barclays | Barclays | Hold Reiterates $14 | Hold | Reiterates | $14 | +4.09% | May 13, 2026 |
| KeyBanc | KeyBanc | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 6, 2026 |
| Jefferies | Jefferies | Buy Maintains $15 → $17 | Buy | Maintains | $15 → $17 | +26.39% | May 6, 2026 |
Financial Forecast
Revenue This Year
3.48B
from 3.31B
Increased by 5.06%
Revenue Next Year
3.67B
from 3.48B
Increased by 5.47%
EPS This Year
0.46
from -0.61
EPS Next Year
0.65
from 0.46
Increased by 41.06%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 3.6B | 3.9B | ||
| Avg | 3.5B | 3.7B | ||
| Low | 3.3B | 3.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 8.7% | 12.2% | ||
| Avg | 5.1% | 5.5% | ||
| Low | 0.4% | -0.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 0.72 | 0.99 | ||
| Avg | 0.46 | 0.65 | ||
| Low | 0.26 | 0.33 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | 112.7% | ||
| Avg | - | 41.1% | ||
| Low | - | -28.2% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.